3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
8
Prostatic Neoplasms
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Osteoporosis
3
Polycystic Ovary Syndrome
2
Obesity
2
Neoplasm Metastasis
2
Lymphoma
2
Leukemia
2
Bone Diseases, Metabolic
2
Vitamin D Deficiency
1
Sexual Dysfunction, Physiological
1
Psoriasis
1
Pain
1
Osteoarthritis
1
Neoplasms
1
Multiple Myeloma
1
Melanoma, Cutaneous Malignant
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Lung Neoplasms
1
Leukemia, Myeloid, Acute
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Insulin Resistance
1
Inflammation
1
Hypertension
1
Giant Cell Tumor of Bone
1
Gastrointestinal Neoplasms
1
Interventions
Gemcitabine
5
Cisplatin
4
enfortumab vedotin
2
Ramucirumab
2
Platinum
2
Docetaxel
2
1,2-diaminocyclohexaneplatinum II citrate
2
vinflunine
1
rucaparib
1
pembrolizumab
1
eribulin
1
enzalutamide
1
dehydroftorafur
1
carotuximab
1
avelumab
1
atezolizumab
1
Standard of Care
1
Specimen Handling
1
Radiotherapy
1
Radiation
1
Paclitaxel
1
N-(3-aminopropyl)-N-(1-(5-benzyl-3-methyl-4-oxo-(1,2)thiazolo(5,4-d)pyrimidin-6-yl)-2-methylpropyl)-4-methylbenzamide
1
Mitozytrex
1
Mitomycin
1
Magnetic Resonance Spectroscopy
1
Interleukin-7
1
Immunoglobulin G
1
Icrucumab
1
IMC-18F1
1
Fluorouracil
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Ureteral Neoplasms
×
Vitamin D
×
Clear all
No trials found.